1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Autosomal Hemophilia A in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydinok, Y; Hüseyinof, A; Kavakli, K; Nisli, G; Polat, A | 1 |
| Aydinok, Y; Coker, I; Hüseyinov, A; Kavakli, K; Nisli, G | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Autosomal Hemophilia A
| Article | Year |
|---|---|
Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Deamino Arginine Vasopressin; Hemophilia A; Hemostatics; Humans; Platelet Activating Factor; von Willebrand Diseases | 1999 |
Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.
Topics: Adolescent; Adult; Calcimycin; Child; Child, Preschool; Deamino Arginine Vasopressin; Female; Hemophilia A; Hemostatics; Humans; Ionophores; Leukocytes; Male; Platelet Activating Factor; Treatment Outcome; von Willebrand Diseases | 2001 |